DE60143984D1 - Neue phenylalanin-derivate - Google Patents
Neue phenylalanin-derivateInfo
- Publication number
- DE60143984D1 DE60143984D1 DE60143984T DE60143984T DE60143984D1 DE 60143984 D1 DE60143984 D1 DE 60143984D1 DE 60143984 T DE60143984 T DE 60143984T DE 60143984 T DE60143984 T DE 60143984T DE 60143984 D1 DE60143984 D1 DE 60143984D1
- Authority
- DE
- Germany
- Prior art keywords
- phenylalanine derivatives
- new phenylalanine
- integrin
- chem
- alpha
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/20—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D239/22—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
- C07D239/80—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
- C07D239/91—Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
- C07D239/96—Two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/08—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
- C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
- C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D265/24—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
- C07D265/26—Two oxygen atoms, e.g. isatoic anhydride
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/15—Six-membered rings
- C07D285/16—Thiadiazines; Hydrogenated thiadiazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/15—Six-membered rings
- C07D285/16—Thiadiazines; Hydrogenated thiadiazines
- C07D285/18—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines
- C07D285/20—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems
- C07D285/22—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D285/24—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D475/00—Heterocyclic compounds containing pteridine ring systems
- C07D475/02—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/582—Recycling of unreacted starting or intermediate materials
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000248728 | 2000-08-18 | ||
JP2001147451 | 2001-05-17 | ||
PCT/JP2001/007039 WO2002016329A1 (fr) | 2000-08-18 | 2001-08-15 | Nouveaux derives de phenylalanine |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60143984D1 true DE60143984D1 (de) | 2011-03-17 |
Family
ID=26598103
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60143984T Expired - Lifetime DE60143984D1 (de) | 2000-08-18 | 2001-08-15 | Neue phenylalanin-derivate |
Country Status (27)
Country | Link |
---|---|
US (4) | US7153963B2 (de) |
EP (1) | EP1288205B1 (de) |
JP (1) | JP3440469B2 (de) |
KR (1) | KR100675036B1 (de) |
CN (1) | CN1325480C (de) |
AT (1) | ATE497385T1 (de) |
AU (2) | AU2001278740B9 (de) |
BG (1) | BG66085B1 (de) |
BR (1) | BRPI0113331B8 (de) |
CA (1) | CA2420040C (de) |
CZ (1) | CZ302653B6 (de) |
DE (1) | DE60143984D1 (de) |
DK (1) | DK1288205T3 (de) |
HU (1) | HU228914B1 (de) |
IL (2) | IL154350A0 (de) |
MX (1) | MXPA03001495A (de) |
NO (1) | NO325738B1 (de) |
NZ (1) | NZ524122A (de) |
PL (1) | PL223152B1 (de) |
PT (1) | PT1288205E (de) |
RU (1) | RU2286340C2 (de) |
SI (1) | SI1288205T1 (de) |
SK (1) | SK287781B6 (de) |
TW (1) | TWI229077B (de) |
UA (1) | UA74385C2 (de) |
WO (1) | WO2002016329A1 (de) |
YU (1) | YU12203A (de) |
Families Citing this family (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6960597B2 (en) | 2000-06-30 | 2005-11-01 | Orth-Mcneil Pharmaceutical, Inc. | Aza-bridged-bicyclic amino acid derivatives as α4 integrin antagonists |
WO2002016329A1 (fr) * | 2000-08-18 | 2002-02-28 | Ajinomoto Co., Inc. | Nouveaux derives de phenylalanine |
AU2001290303A1 (en) | 2000-09-29 | 2002-04-15 | Ajinomoto Co., Inc. | Novel phenylalanine derivatives |
JP4164871B2 (ja) * | 2001-07-26 | 2008-10-15 | 味の素株式会社 | 新規フェニルプロピオン酸誘導体 |
WO2003053926A1 (fr) * | 2001-12-13 | 2003-07-03 | Ajinomoto Co.,Inc. | Nouveau derive de phenylalanine |
AU2003211560A1 (en) * | 2002-02-20 | 2003-09-09 | Ajinomoto Co., Inc. | Novel phenylalanine derivative |
CN100436429C (zh) * | 2003-02-20 | 2008-11-26 | 味之素株式会社 | 具有喹唑二酮骨架的苯丙氨酸衍生物的制造方法及制造中间体 |
EP3216449A1 (de) | 2003-11-14 | 2017-09-13 | EA Pharma Co., Ltd. | Präparat zur oralen verabreichung aus phenylalaninderivaten |
JP4780522B2 (ja) * | 2003-11-14 | 2011-09-28 | 味の素株式会社 | フェニルアラニン誘導体の固体分散体または固体分散体医薬製剤 |
CN1886385B (zh) * | 2003-11-27 | 2013-02-27 | 味之素株式会社 | 苯丙氨酸衍生物的结晶及其制造方法 |
EP2615087A3 (de) * | 2003-12-22 | 2013-08-07 | Ajinomoto Co., Inc. | Phenylalaninderivate |
US7618981B2 (en) * | 2004-05-06 | 2009-11-17 | Cytokinetics, Inc. | Imidazopyridinyl-benzamide anti-cancer agents |
US20060024295A1 (en) * | 2004-06-04 | 2006-02-02 | Genentech, Inc. | Method for treating lupus |
BRPI0510915A (pt) | 2004-06-04 | 2007-11-13 | Genentech Inc | método para o tratamento da esclerose múltipla e artigo manufaturado |
KR20080024536A (ko) * | 2005-06-21 | 2008-03-18 | 아지노모토 가부시키가이샤 | 페닐알라닌 유도체의 결정, 이의 제조방법 및 이의 용도 |
CN101360736A (zh) * | 2005-11-23 | 2009-02-04 | 阿斯利康(瑞典)有限公司 | L-丙氨酸衍生物 |
ZA200805192B (en) | 2005-12-29 | 2009-11-25 | Lexicon Pharmaceuticals Inc | Multicyclic amino acid derivatives and methods of their use |
AR059224A1 (es) | 2006-01-31 | 2008-03-19 | Jerini Ag | Compuestos para la inhibicion de integrinas y uso de estas |
UY30244A1 (es) * | 2006-03-30 | 2007-11-30 | Tanabe Seiyaku Co | Un proceso para preparar derivados de tetrahidroquinolina |
AR060901A1 (es) | 2006-05-12 | 2008-07-23 | Jerini Ag | Compuestos heterociclicos para la inhibicion de integrinas y uso de estos |
WO2007141473A1 (en) * | 2006-06-09 | 2007-12-13 | Astrazeneca Ab | N-(benzoyl)-o- [2- (pyridin- 2 -ylamino) ethyl] -l-tyrosine derivatives and related compounds as a5b1 antagonists for the treatment of solid tumors |
US7879837B2 (en) | 2006-06-19 | 2011-02-01 | Toray Industries, Inc. | Therapeutic or prophylactic agent for multiple sclerosis |
US7893046B2 (en) * | 2006-06-20 | 2011-02-22 | Toray Industries, Inc. | Therapeutic or prophylactic agent for leukemia |
EP2103601B1 (de) * | 2006-11-22 | 2012-03-14 | Ajinomoto Co., Inc. | Verfahren zur herstellung von phenylalaninderivaten mit chinazolindiongerüsten, und zwischenprodukte für die herstellung |
WO2008093065A1 (en) * | 2007-01-29 | 2008-08-07 | Astrazeneca Ab | L-ALANINE DERIVATIVES AS α5βL ANTAGONISTS |
CA2714335A1 (en) | 2007-02-20 | 2008-08-28 | Merrimack Pharmaceuticals, Inc. | Methods of treating multiple sclerosis by administration of alpha-fetoprotein in combination with an integrin antagonist |
WO2008125811A1 (en) * | 2007-04-11 | 2008-10-23 | Astrazeneca Ab | N-[HETEROARYLCARBONYL]-S-THIENYL-L-ALANINE DERIVATIVES AS α5β1 ANTAGONISTS |
ES2525065T3 (es) | 2008-04-11 | 2014-12-17 | Merrimack Pharmaceuticals, Inc. | Ligadores de seroalbúmina humana y sus conjugados |
TW201014605A (en) | 2008-09-16 | 2010-04-16 | Genentech Inc | Methods for treating progressive multiple sclerosis |
KR20110112301A (ko) | 2008-11-18 | 2011-10-12 | 메리맥 파마슈티컬즈, 인크. | 인간 혈청 알부민 링커 및 그 콘쥬게이트 |
WO2010075249A2 (en) | 2008-12-22 | 2010-07-01 | Genentech, Inc. | A method for treating rheumatoid arthritis with b-cell antagonists |
WO2011122620A1 (ja) | 2010-03-29 | 2011-10-06 | 味の素株式会社 | フェニルアラニン誘導体を含有する医薬製剤 |
JP6109568B2 (ja) * | 2010-03-29 | 2017-04-05 | Eaファーマ株式会社 | フェニルアラニン誘導体の塩の結晶 |
EP2769222A1 (de) | 2011-10-17 | 2014-08-27 | Westfälische Wilhelms-Universität Münster | Verfahren zur pml-risikobeurteilung und zugehörige vorrichtung |
WO2013101771A2 (en) | 2011-12-30 | 2013-07-04 | Genentech, Inc. | Compositions and method for treating autoimmune diseases |
AR091305A1 (es) | 2012-01-31 | 2015-01-28 | Genentech Inc | ANTICUERPOS ANTI-IgE Y SUS METODOS DE USO |
MX351225B (es) * | 2012-04-24 | 2017-10-05 | Ea Pharma Co Ltd | Derivado de sulfonamida y uso medicinal del mismo. |
WO2014036520A1 (en) | 2012-08-30 | 2014-03-06 | Merrimack Pharmaceuticals, Inc. | Combination therapies comprising anti-erbb3 agents |
MX370666B (es) * | 2013-06-11 | 2019-12-19 | Celgene Int Ii Sarl | Novedosos moduladores del receptor de péptido tipo glucagón 1 (glp-1). |
EP3052515A4 (de) | 2013-09-30 | 2017-03-15 | The Regents of the University of California | Anti-alphavbeta1-integrin-verbindungen und verfahren |
MX2016005528A (es) * | 2013-10-29 | 2016-10-03 | Ea Pharma Co Ltd | Derivado de sulfonamida y uso farmaceutico del mismo. |
JP6580053B2 (ja) * | 2014-09-29 | 2019-09-25 | Eaファーマ株式会社 | 潰瘍性大腸炎の治療用医薬組成物 |
US10307535B2 (en) | 2014-12-19 | 2019-06-04 | Medtronic Minimed, Inc. | Infusion devices and related methods and systems for preemptive alerting |
US10214522B2 (en) | 2015-03-10 | 2019-02-26 | The Regents Of The University Of California | Anti-alphavbeta1 integrin inhibitors and methods of use |
KR20180075537A (ko) | 2015-10-06 | 2018-07-04 | 제넨테크, 인크. | 다발성 경화증을 치료하기 위한 방법 |
ES2856125T3 (es) | 2016-02-05 | 2021-09-27 | Ea Pharma Co Ltd | Derivado de sulfonamida y composición farmacéutica que contiene la misma |
EP3810085A1 (de) | 2018-06-20 | 2021-04-28 | Progenity, Inc. | Behandlung der erkrankung des gastrointestinaltraktes mit einem integrin-inhibitor |
WO2020092383A1 (en) | 2018-10-30 | 2020-05-07 | Gilead Sciences, Inc. | Compounds for inhibition of alpha 4 beta 7 integrin |
KR20240015737A (ko) | 2018-10-30 | 2024-02-05 | 길리애드 사이언시즈, 인코포레이티드 | 알파4베타7 인테그린 억제제로서의 퀴놀린 유도체 |
US11174256B2 (en) | 2018-10-30 | 2021-11-16 | Gilead Sciences, Inc. | Imidazopyridine derivatives |
EP3873605A1 (de) | 2018-10-30 | 2021-09-08 | Gilead Sciences, Inc. | Verbindungen zur inhibierung von alpha4-beta7-integrin |
US11578069B2 (en) | 2019-08-14 | 2023-02-14 | Gilead Sciences, Inc. | Compounds for inhibition of α4 β7 integrin |
WO2022072156A1 (en) | 2020-10-01 | 2022-04-07 | Orthotrophix, Inc. | Hard tissue therapeutics |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2419928A1 (fr) | 1978-03-15 | 1979-10-12 | Metabio Joullie Sa | Nouveaux derives de la n-phenylalanine, leur preparation et leur application comme medicaments |
DE4111394A1 (de) | 1991-04-09 | 1992-10-15 | Behringwerke Ag | Amidinophenylalaninderivate, verfahren zu deren herstellung, deren verwendung und diese enthaltende mittel |
US6306840B1 (en) | 1995-01-23 | 2001-10-23 | Biogen, Inc. | Cell adhesion inhibitors |
HU914U (en) | 1995-04-19 | 1996-10-28 | Koevesi | Machine tool for contour turning |
PT968194E (pt) | 1997-02-28 | 2004-08-31 | Pfizer Prod Inc | Atropisomeros de 3-aril-4(3h)-quinazolinonas e sua utilizacao como antagonistas dos receptores ampa |
AU756696B2 (en) | 1997-07-31 | 2003-01-23 | Elan Pharmaceuticals, Inc. | Substituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4 |
EP0994896A1 (de) * | 1997-07-31 | 2000-04-26 | Elan Pharmaceuticals, Inc. | Sulfonylierte dipeptide, die die vla-4 vermittelte adhäsion von leukozyten inhibieren |
JP3727536B2 (ja) | 1997-08-22 | 2005-12-14 | エフ.ホフマン−ラ ロシュ アーゲー | N−アルカノイルフェニルアラニン誘導体 |
PT1005445E (pt) * | 1997-08-22 | 2004-09-30 | Hoffmann La Roche | Derivados de n-alcanoilfenilalanina |
US6197794B1 (en) * | 1998-01-08 | 2001-03-06 | Celltech Therapeutics Limited | Phenylalanine derivatives |
MY153569A (en) | 1998-01-20 | 2015-02-27 | Mitsubishi Tanabe Pharma Corp | Inhibitors of ?4 mediated cell adhesion |
US6329372B1 (en) * | 1998-01-27 | 2001-12-11 | Celltech Therapeutics Limited | Phenylalanine derivatives |
DE69919334T2 (de) | 1998-02-26 | 2005-08-04 | Celltech Therapeutics Ltd., Slough | Phenylalaninderivate als inhibitoren von alpha4 integrinen |
GB2354440A (en) | 1999-07-20 | 2001-03-28 | Merck & Co Inc | Aryl amides as cell adhesion inhibitors |
ATE355269T1 (de) | 1999-11-18 | 2006-03-15 | Ajinomoto Kk | Phenylalaninderivate |
BR0016195A (pt) | 1999-12-06 | 2002-08-13 | Hoffmann La Roche | 4-pirimidinil-n-acil-l-fenilalaninas |
WO2001042215A1 (en) | 1999-12-06 | 2001-06-14 | F. Hoffmann-La Roche Ag | 4-pyridinyl-n-acyl-l-phenylalanines |
WO2001047868A1 (fr) | 1999-12-28 | 2001-07-05 | Ajinomoto Co., Inc. | Nouveaux derives de phenylalanine |
AU2001242743A1 (en) | 2000-03-23 | 2001-10-03 | Ajinomoto Co. Inc. | Novel phenylalanine derivative |
US6960597B2 (en) | 2000-06-30 | 2005-11-01 | Orth-Mcneil Pharmaceutical, Inc. | Aza-bridged-bicyclic amino acid derivatives as α4 integrin antagonists |
WO2002016329A1 (fr) | 2000-08-18 | 2002-02-28 | Ajinomoto Co., Inc. | Nouveaux derives de phenylalanine |
MY129000A (en) | 2000-08-31 | 2007-03-30 | Tanabe Seiyaku Co | INHIBITORS OF a4 MEDIATED CELL ADHESION |
AU2001290303A1 (en) | 2000-09-29 | 2002-04-15 | Ajinomoto Co., Inc. | Novel phenylalanine derivatives |
JP4164871B2 (ja) | 2001-07-26 | 2008-10-15 | 味の素株式会社 | 新規フェニルプロピオン酸誘導体 |
WO2003053926A1 (fr) | 2001-12-13 | 2003-07-03 | Ajinomoto Co.,Inc. | Nouveau derive de phenylalanine |
AU2003211560A1 (en) | 2002-02-20 | 2003-09-09 | Ajinomoto Co., Inc. | Novel phenylalanine derivative |
CN100436429C (zh) | 2003-02-20 | 2008-11-26 | 味之素株式会社 | 具有喹唑二酮骨架的苯丙氨酸衍生物的制造方法及制造中间体 |
CN1886385B (zh) | 2003-11-27 | 2013-02-27 | 味之素株式会社 | 苯丙氨酸衍生物的结晶及其制造方法 |
EP2615087A3 (de) | 2003-12-22 | 2013-08-07 | Ajinomoto Co., Inc. | Phenylalaninderivate |
KR20080024536A (ko) | 2005-06-21 | 2008-03-18 | 아지노모토 가부시키가이샤 | 페닐알라닌 유도체의 결정, 이의 제조방법 및 이의 용도 |
-
2001
- 2001-08-15 WO PCT/JP2001/007039 patent/WO2002016329A1/ja active IP Right Grant
- 2001-08-15 PL PL361383A patent/PL223152B1/pl unknown
- 2001-08-15 AU AU2001278740A patent/AU2001278740B9/en not_active Ceased
- 2001-08-15 SK SK191-2003A patent/SK287781B6/sk not_active IP Right Cessation
- 2001-08-15 YU YU12203A patent/YU12203A/sh unknown
- 2001-08-15 EP EP01956901A patent/EP1288205B1/de not_active Expired - Lifetime
- 2001-08-15 JP JP2002521430A patent/JP3440469B2/ja not_active Expired - Lifetime
- 2001-08-15 CA CA002420040A patent/CA2420040C/en not_active Expired - Fee Related
- 2001-08-15 DK DK01956901.1T patent/DK1288205T3/da active
- 2001-08-15 CZ CZ20030481A patent/CZ302653B6/cs not_active IP Right Cessation
- 2001-08-15 BR BRPI0113331A patent/BRPI0113331B8/pt not_active IP Right Cessation
- 2001-08-15 RU RU2003104821/04A patent/RU2286340C2/ru not_active IP Right Cessation
- 2001-08-15 KR KR1020037002277A patent/KR100675036B1/ko active IP Right Grant
- 2001-08-15 SI SI200130990T patent/SI1288205T1/sl unknown
- 2001-08-15 AU AU7874001A patent/AU7874001A/xx active Pending
- 2001-08-15 AT AT01956901T patent/ATE497385T1/de active
- 2001-08-15 UA UA2003021359A patent/UA74385C2/uk unknown
- 2001-08-15 CN CNB018175112A patent/CN1325480C/zh not_active Expired - Fee Related
- 2001-08-15 DE DE60143984T patent/DE60143984D1/de not_active Expired - Lifetime
- 2001-08-15 PT PT01956901T patent/PT1288205E/pt unknown
- 2001-08-15 MX MXPA03001495A patent/MXPA03001495A/es active IP Right Grant
- 2001-08-15 IL IL15435001A patent/IL154350A0/xx unknown
- 2001-08-15 HU HU0302997A patent/HU228914B1/hu not_active IP Right Cessation
- 2001-08-15 NZ NZ524122A patent/NZ524122A/en not_active IP Right Cessation
- 2001-08-17 TW TW090120309A patent/TWI229077B/zh not_active IP Right Cessation
-
2002
- 2002-11-21 US US10/300,856 patent/US7153963B2/en not_active Expired - Lifetime
-
2003
- 2003-02-09 IL IL154350A patent/IL154350A/en not_active IP Right Cessation
- 2003-02-14 BG BG107555A patent/BG66085B1/bg unknown
- 2003-02-17 NO NO20030744A patent/NO325738B1/no not_active IP Right Cessation
-
2006
- 2006-05-30 US US11/442,141 patent/US7872125B2/en active Active
-
2010
- 2010-11-22 US US12/951,180 patent/US8222405B2/en not_active Expired - Fee Related
-
2012
- 2012-06-15 US US13/524,318 patent/US8426588B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60143984D1 (de) | Neue phenylalanin-derivate | |
ATE355269T1 (de) | Phenylalaninderivate | |
ATE464299T1 (de) | Neues phenylalaninderivat | |
FR20C1039I2 (fr) | Derives de l'uk-2a | |
ECSP066311A (es) | Derivados de la piperazina y su uso como agentes terapéuticos | |
EP2615087A3 (de) | Phenylalaninderivate | |
MA27126A1 (fr) | 3'PROMEDICAMENTS DE 2'-DESOXY- β-L-NUCLEOSIDES | |
CY1108610T1 (el) | Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες | |
EE200300307A (et) | 1,5-bensotiasepiinid ja nende kasutamine antilipideemiliste vahenditena | |
PT896533E (pt) | Pentafluorobenzenosulfonamidas e analogos | |
NO20040198L (no) | Dolastatin 10 derivater | |
DE59910836D1 (de) | Dermal applizierbare wasserhaltige formulierungen von parasitiziden | |
NO20054662D0 (no) | Farmasoytisk sammensetning omfattende 5-metyl-2-2'-(klor-6'-fluoranilin)fenyleddiksyre | |
DK1421094T3 (da) | 4" deoxy 4" (S) aminoavermectinderivater | |
ATE330958T1 (de) | Pyrazino 1'2':1,6öpyrido 3,4-böindolderivate | |
MA27240A1 (fr) | Derives d'imidazoquinoleine | |
PT878195E (pt) | Utilizacao de um composto 2-aroil-3-arilbenzo(b)tiofeno para a reducao de fibrinogenio | |
ITRM20000624A0 (it) | Uso di derivati dell'acidocinnamico come agenti insetticidi. | |
DE50310743D1 (de) | Wässrige formulierungen von (2-hydroxymethyl-indanyl-4-oxy)-phenyl-4,4,4- trifluorbutan-1-sulfonat | |
NO20000275D0 (no) | Alfs slipsholder | |
ES2181160T3 (es) | Derivados de 1,4-dihidropiridina y su utilizacion en terapia. | |
UA3771S (uk) | Етикетка лікарського препарату "цитрамон-екстра" | |
ITRC20000004V0 (it) | Deodorante - souvenir "i calandreddhi" | |
DE29905807U1 (de) | Herren-Retro-Body | |
UA3098S (uk) | Стілець "ризький" |